Jonas Hillebrandt
Overview
Explore the profile of Jonas Hillebrandt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tometten I, Brandt T, Schlotz M, Stumpf R, Landmann S, Kantauskaite M, et al.
Front Immunol
. 2025 Jan;
15:1476294.
PMID: 39877366
Background: The emergence of novel SARS-CoV-2 variants challenges immunity, particularly among immunocompromised kidney transplant recipients (KTRs). To address this, vaccines have been adjusted to circulating variants. Despite intensive vaccination efforts,...
2.
Tometten I, Landmann S, Kantauskaite M, Lamberti J, Hillebrandt J, Muller L, et al.
J Infect Dis
. 2022 Nov;
227(5):641-650.
PMID: 36408631
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an important prophylactic measure in kidney transplant recipients (KTRs), but the immune response is often impaired. Here, we examined the...
3.
Muller L, Andree M, Moskorz W, Drexler I, Hauka S, Ptok J, et al.
Front Aging
. 2022 Oct;
3:1027885.
PMID: 36313184
We provide follow-up data on the humoral immune response after COVID-19 vaccinations of two distinct cohorts aged below 60 and over 80 years to screen for age-related differences in the...
4.
Kantauskaite M, Muller L, Hillebrandt J, Lamberti J, Fischer S, Kolb T, et al.
Clin Transplant
. 2022 Aug;
36(11):e14790.
PMID: 35997031
Modification of vaccination strategies is necessary to improve the immune response to SARS-CoV-2 vaccination in kidney transplant recipients (KTRs). This multicenter observational study analyzed the effects of the third SARS-CoV-2...
5.
Kolb T, Fischer S, Muller L, Lubke N, Hillebrandt J, Andree M, et al.
Kidney360
. 2022 Apr;
2(9):1491-1498.
PMID: 35373105
Background: Patients with kidney failure on dialysis or after renal transplantation have a high risk for severe COVID-19 infection, and vaccination against SARS-CoV-2 is the only expedient prophylaxis. Generally, immune...
6.
Kantauskaite M, Muller L, Kolb T, Fischer S, Hillebrandt J, Ivens K, et al.
Am J Transplant
. 2021 Sep;
22(2):634-639.
PMID: 34551181
Kidney transplant recipients (KTRs) are extremely vulnerable to SARS-CoV-2 infection and show an impaired immune response to SARS-CoV-2 vaccination. We analyzed factors related to vaccination efficiency in KTRs. In a...
7.
Muller L, Andree M, Moskorz W, Drexler I, Walotka L, Grothmann R, et al.
Clin Infect Dis
. 2021 Apr;
73(11):2065-2072.
PMID: 33906236
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to the development of various vaccines. Real-life data on immune responses elicited in the most vulnerable group of...